Cardiff Oncology reports Q3 2026 results, preps Phase 3 onvansertib trial for Q1 2027Nov 16Clinical readoutBeiGeneCardiff OncologyUpdated
Galmed unveils LNP cardiac-targeted Aramchol formulation with Barcode NanotechJul 16PartnershiparamcholGalmed Pharmaceuticals Ltd